Different temporal requirements for the LRR transmembrane receptors Tartan and Toll-2 in the formation of contractile interfaces at compartmental boundaries

Abstract

Compartmental boundaries physically separate groups of epithelial cells, a property fundamental for the organization of the body plan in both insects and vertebrates. In many examples, this physical separation has been shown to be the consequence of a regulated increase in contractility of the actomyosin cortex at boundary cell-cell interfaces, a property important in developmental morphogenesis beyond compartmental boundary formation. In this study, we took an unbiased screening approach to identify cell surface receptors required for actomyosin enrichment and polarisation at parasegmental boundaries (PSBs) in early Drosophila embryos, leading us to uncover different temporal requirements for two LRR receptors, Tartan and Toll-2. First, we find that Tartan is required during germband extension for actomyosin enrichment at PSBs, confirming an earlier report. Next, by following in real time the dynamics of loss of boundary straightness in tartan mutant embryos compared to wildtype and ftz mutant embryos, we show that Tartan is not required beyond germband extension. At this stage, actomyosin enrichment at PSBs becomes regulated by Wingless signalling. We find that Wingless signalling regulates Toll-2 expression and we show that Toll-2 is required for planar polarization of actomyosin after the completion of germ-band extension. Thus the formation of contractile interfaces at PSBs depends on a dynamic set of LRR receptors cues. Our study also suggests that the number of receptor cues is small and that the receptors are interchangeable.

Notch-dependent and -independent transcription are modulated by tissue movements at gastrulation

“…Embryos obtained from crossing His2Av-RFP /+ females and males were dechorionated, glued with heptane glue to a coverslip, and covered with Voltalef medium (Samaro). Injections were performed only on pre-nc10 embryos using pulled glass needles and dextrans diluted in injection buffer (0.1 mM sodium phosphate buffer, 5 mM KCl, Sharrock et al, 2021 ) at a concentration of 0.125 mg/ml for Dextran-40kDa-FITC (Sigma-Aldrich FD40S) and 0.25 mg/ml for Dextran-70kDa-FITC (Sigma-Aldrich 46945).…”